Reliability of Normal Findings on MR Imaging for Excluding the Diagnosis of Vasculitis of the Central Nervous System
AJR 177:455-459, Wasserman, B.A.,et al, 2001
Multifocal Dural Enhancement Associated with Temporal Arteritis
Arch Neurol 57:119-122, Joelson,E.,et al, 2000
A Six-Year-Old Girl with Tick paralysis
NEJM 342:90-94, Felz,M.W.,et al, 2000
Neurologic Complications of the Reactivation of Varicella-Zoster Virus
NEJM 342:635-645, Gilden,D.H.,et al, 2000
Cardiac Dysfunction in Neuromuscular Diseases
The Neurologist 6:67-82, Pourmand,R., 2000
Neurological Manifestations of Dengue Infection
Lancet 355:1053-1059, Solomon,T.,et al, 2000
Long-Term outcome in Patients With Guillain-Barre Syndrome Requiring Mechanical Ventilation
Neurol 54:2311-2315, Fletcher,D.D.,et al, 2000
The DYT1 Phenotype and Guidelines for Diagnostic Testing
Neurol 54:1746-1753,1718, Bressman,S.B.,et al, 2000
Human Immunodeficiency Virus-Associated Pure motor Lumbosacral Polyradiculopathy
Arch Neurol 57:1034-1039, Benatar,M.G. & Eastman,R.W., 2000
Guillain-Barre Syndrome: An Unusual Presentation of West Nile Virus Infection
Neurol 55:144-146, Ahmed,S. et al, 2000
Influenza Vaccine and the Risk of Relapse of Guillain-Barre Syndrome
Neurol 55:452-453, Wijdicks,E.F.M. et al, 2000
Disease Progression in Sporadic Inclusion Body Myositis: Observations in 78 Patients
Neurol 55:296-198, Peng,A. et al, 2000
Dilated Stomach and Weak Muscles
Lancet 356:1898, Rigby,S.P.,et al, 2000
Guillain-Barre Syndrome in a Patient with Non-Hodgkins Lymphoma
Ann Oncol 11:217-220, Schwenk,D.Re.,et al, 2000
Benign Acute Childhood Myositis, Laboratory and Clinical Features
Neurol 53:2127-2131, Mackay,M.T.,et al, 1999
Clinicopath Conf,Guillain-Barre Syndrome, Campylobacter Jejuni Enteritis,Case 39-1999
NEJM 341:1996-2003, , 1999
Intravenous Immunoglobulin in the Treatment of Autoimmune Neuromuscular Diseases:Present Status and Practical Therapeutic Guidelines
Muscle & Nerve 22:1479-1497, Dalakas,M.C., 1999
Neurology and the Skin
JNNP 66:417-430, Hurko,O.&Provost,T.T., 1999
Outcome in Severe Pediatric Guillain-Barre Syndrome after Immunotherapy or Supportive Care
Neurol 52:1494-1497, Graf,W.D.,et al, 1999
Chronic Cryptogenic Sensory Polyneuropathy,Clinical and Laboratory Characteristics
Arch Neurol 56:540-547, 519, Wolfe,G.I.,et al, 1999
Infantile Neuroaxonal Dystrophy,Clinical Spectrum and Diagnostic Criteria
Neurol 52:1472-1478, Nardocci,N.,et al, 1999
Brain Biopsy in Primary Angiitis of the Central Nervous System
Neurol 53:858-860, Alrawi,A.,et al, 1999
Neurologic Complications Associated with Hepatitis C Virus Infection
Neurol 53:861-864, Tembl,J.I.,et al, 1999
Polyarteritis Nodosa Presenting as Temporal Arteritis in a 9-Year-Old Child
AJNR 20:167-171, Bert,R.J.,et al, 1999
Pain and the Guillain-Barre Syndrome in Children Under 6 Years
J Pediatr 134:773-776, Nguyen,D.K.,et al, 1999
Focal, Steroid Responsive Myositis Causing Dropped Head Syndrome
Muscle & Nerve 22:769-771, Biran,I.,et al, 1999
Intravenous Immunoglobulin Treatment in Neurologic Disorders
Arch Neurol 56:1025-1027,1032, Sorensen,P.S., 1999
Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?
Arch Neurol 56:1028-1032, Karussis,D.&Abramsky,O., 1999
Tracheostomy, In Guillain- Barre Syndrome
Muscle & Nerve 22:1058-1062, Lawn,N.D.&Wijdicks,E.F.M., 1999
Prognostic Factors of Guillain-Barre Syndrome After Intravenous Immunoglobulin or Plasma Exchange?
Neurol 53:598-604, Visser,L.H.,et al, 1999
A Sartorial Challenge
Lancet 354:996, Reading,P.J.,et al, 1999
Multiple Sclerosis, Side Effects of Interferon Beta Therapy and Their Management
Neurol 53:1622-1627, Walther,E.U.&Hohlfeld,R., 1999
SIADH as the First Symptom of Guillain-Barre Syndrome
Neurol 53:1365, Hofmann,O.,et al, 1999
Weak at the Knees
Lancet 354:1696, Webster,G.&Beynon,H., 1999
Recurrent Orbital Myositis,Report of a Familial Incidence
Arch Neurol 56:1407-1409, Maurer,I.&Zierz,S., 1999
Control of Primary Angiitis of the CNS Associated with Cerebral Amyloid Angiopathy by Cyclophosphamide Alone
Neurol 52:660-662, Fountain,N.B.&Lopes,B.S., 1999
Fatal Guillain-Barre Syndrome
Neurol 52:635-638, Lawn,N.D.&Wijdicks,E.F.M., 1999
Clinicopath Conf,Wegener's Granulomatosis with Pachymeningeal Granulomatous Inflammation, Case 9-1999
NEJM 340:945-953, , 1999
Neurological Manifestations of Chronic Hepatitis C
J Neurol 246:486-491, Heckmann, J.G.,et al, 1999
Ramsay Hunt Syndrome Associated with Brain Stem Enhancement
AJNR 20:278-280, Sartoretti-Schefer,S.,et al, 1999
The Spectrum of Antecedent Infections in Guillain-Barre Syndrome
Neurol 51:1110-1115, Jacobs,B.C.,et al, 1998
The Guillain-Barre Syndrome and the 1992-1993 and 1993-1994 Influenza Vaccines
NEJM 339:1797-1802,1845, Lasky,T.,et al, 1998
MR Differential Diagnosis of Normal-Pressure Hydrocephalus and Alzheimer Disease:Significance of Perihippocampal Fissures
AJNR 19:813-819, Holodny,A.I.,et al, 1998
Acute Inflammatory Demyelinating Polyradiculopathy in Children:Clinical and Electrodiagnostic Studies
Ann Neurol 44:350-356, Delanoe,C.,et al, 1998
Minimal Number of Plasma Exchanges Needed to Reduce Immunoglobulin in Guillain-Barre Syndrome
Neurol 51:875-877, Yuki,N.,et al, 1998
Alcohol-Related Acute Axonal Polyneuropathy,A Differential Diagnosis of Guillain-Barre Syndrome
Arch Neurol 55:1329-1334, Wohrle,J.C.,et al, 1998
Occult Giant Cell Arteritis:Ocular Manifestations
Am J Ophthalmol 125:521-526, Hayreh,S.S.,et al, 1998
Angiographically Defined Primary Angiitis of the CNS, Is It Really Benign
Neurol 51:183-188, Woolfenden,A.R.,et al, 1998
A Rash, Circulating Anticoagulant, Then Meningitis
Lancet 351:1856, Schanen,A.,et al, 1998
Guillain-Barre Syndrome
Lancet 352:635-641, Hahn,A.F., 1998